United States Neuropathic Pain Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2025

1.       Report Overview

1.1.    Report Description

1.2.    Research Methods

1.3.    Research Approaches

2.       Executive Summary

3.       Market Overview

3.1.    Introduction

3.2.    Market Dynamics

3.2.1.Drivers

3.2.2.Restraints

3.2.3.Opportunities

3.2.4.Challenges

3.3.    PEST-Analysis

3.4.    Porter's Diamond Model for the United States Neuropathic Pain Market

3.5.    IGR-Growth Matrix Analysis

3.6.    Competitive Landscape in the United States Neuropathic Pain Market

4.       United States Neuropathic Pain Market by Type

4.1.    Phantom Limb Pain

4.2.    Trigeminal Neuralgia

4.3.     Post Herpetic Neuralgia

4.4.    Post-traumatic Neuropathy

5.       United States Neuropathic Pain Market by Indication

5.1.    Spinal Stenosis

5.2.    Diabetic Neuropathy

6.       United States Neuropathic Pain Market by Diagnosis

6.1.     Imaging Physical Examination

6.1.1. Electromyography

6.1.2. MRI

6.1.3.  CT

6.2.     Blood Tests

7.       United States Neuropathic Pain Market by Treatment

7.1.    Medication Type

7.2.    NSAIDs Type

7.2.1. Naproxen

7.2.2. Ibuprofen

7.2.3. Others

7.3.    Antidepressant Drugs Type

7.3.1. Tricyclic Antidepressants

7.3.2. Serotonin Noradrenaline

7.4.     Multimodal Therapy

8.       United States Neuropathic Pain Market by Distribution Channel

8.1.    Retail Pharmacies and Drug Stores

8.2.     Online Pharmacies

9.       United States Neuropathic Pain Market by End User

9.1.    Hospitals

9.2.    Clinics

10.   Company Profiles

10.1.                     Company 1

10.2.                     Company 2

10.3.                     Company 3

10.4.                     Company 4

10.5.                     Company 5